Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for chronic neuropathic pain in spinal cord injury with or without inflammatory pressure ulcers
2017-003930-10Phase 3Active
- Sponsor
- Recherche et enseignement en douleur, anesthesie reanimation
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ketamine in Neuralgia and spinal cord injury (SCI) (2 arms), sponsored by Recherche et enseignement en douleur, anesthesie reanimation. Started Feb 2018; status: active.
02
Drugs
ketamine
03
Conditions
Neuralgiaspinal cord injury (SCI)
Beyond the preview
Go deeper on 2017-003930-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003930-10.